WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences

NEXT STORY
CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
PREV STORY
BriaCell Files New Provisional Patent Application for Antibody-Based Treatment of Infectious Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunocore Announces Upcoming Presentations at the European Society for Medical Oncology (ESMO) Congress 2021

author_avatar
NASDAQ Market News

Vifor Pharma and Akebia Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval

                                                   --   Vifor Pharma Commits to Exclusive Distribution of Vadadustat to Fresenius Medical Care North America ...

author_avatar
NASDAQ Market News

OncoMed Enrolls First Patient in Phase 1b Clinical Trial of its Anti-DLL4/VEGF Bispecific Antibody in Patients with Platinum-Resistant Ovarian Cancer

REDWOOD CITY, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a ...

author_avatar
NASDAQ Market News